Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-25 5:16 pm Purchase |
2025-02-13 | 13G | Edesa Biotech, Inc. EDSA |
Stonepine Capital Management, LLC | 693,551 9.900% |
693,551 (New Position) |
Filing History |
| 2025-02-18 5:48 pm Purchase |
2025-02-12 | 13D | Edesa Biotech, Inc. EDSA |
Velan Capital Investment Management LP | 693,551 9.990% |
630,059 (+992.34%) |
Filing History |
| 2025-02-18 4:15 pm Sale |
2025-02-13 | 13G | Edesa Biotech, Inc. EDSA |
SATTERFIELD THOMAS A JR | 0 0.000% |
-232,161 (Position Closed) |
Filing History |
| 2025-02-14 5:16 pm Purchase |
2025-02-12 | 13D | Edesa Biotech, Inc. EDSA |
Nijhawan Pardeep | 1,596,581 19.990% |
921,257 (+136.42%) |
Filing History |
| 2025-02-12 08:00 am Purchase |
2024-12-31 | 13G | Edesa Biotech, Inc. EDSA |
SATTERFIELD THOMAS A JR | 232,161 6.700% |
56,117 (+31.88%) |
Filing History |
| 2024-11-01 8:50 pm Purchase |
2024-10-30 | 13D | Edesa Biotech, Inc. EDSA |
Nijhawan Pardeep | 675,324 19.990% |
675,324 (New Position) |
Filing History |
| 2024-06-03 4:10 pm Purchase |
2024-05-30 | 13G | Edesa Biotech, Inc. EDSA |
SATTERFIELD THOMAS A JR | 176,044 5.470% |
176,044 (New Position) |
Filing History |
| 2024-01-29 4:29 pm Purchase |
2023-12-31 | 13G | Edesa Biotech, Inc. EDSA |
Velan Capital Investment Management LP | 63,492 1.970% |
63,492 (New Position) |
Filing History |
| 2024-01-16 5:03 pm Purchase |
2023-01-08 | 13D | Edesa Biotech, Inc. EDSA |
Pardeep Nijhawan Medicine Professional Corp | 630,012 19.300% |
630,012 (New Position) |
Filing History |
| 2023-08-21 5:01 pm Purchase |
2023-08-04 | 13D | Edesa Biotech, Inc. EDSA |
Pardeep Nijhawan Medicine Professional Corp | 654,985 20.900% |
23,791 (+3.77%) |
Filing History |
| 2023-01-13 5:28 pm Sale |
2023-01-10 | 13D | Edesa Biotech, Inc. EDSA |
Lumira Capital Investment Management Inc. | 249,853 9.000% |
-36,228 (-12.66%) |
Filing History |
| 2023-01-06 4:08 pm Purchase |
2022-12-23 | 13G | Edesa Biotech, Inc. EDSA |
Velan Capital Investment Management LP | 253,968 8.780% |
253,968 (New Position) |
Filing History |
| 2022-11-08 12:18 pm Purchase |
2022-11-02 | 13D | Edesa Biotech, Inc. EDSA |
Pardeep Nijhawan Medicine Professional Corp | 631,194 22.100% |
214,383 (+51.43%) |
Filing History |
| 2020-09-18 08:00 am Purchase |
2020-09-17 | 13D | Edesa Biotech, Inc. EDSA |
Edesa Biotech Inc. EDSA |
473,887 34.400% |
473,887 (New Position) |
Filing History |